Leishmaniasis Vaccines
New leishmaniasis vaccines research from World Health Organization discussed
Published in Vaccine Weekly, February 4th, 2009
Research findings, 'First generation leishmaniasis vaccines: a review of field efficacy trials,' are discussed in a new report. According to recent research published in the journal Vaccine, "First generation candidate vaccines against leishmaniasis, prepared using inactivated whole parasites as their main ingredient, were considered as promising because of their relative ease of production and low cost. These vaccines have been the subject of many investigations over several decades and are the only leishmaniasis vaccine candidates which have undergone phase 3 clinical trial evaluation."
"Although the studies demonstrated the safety of the vaccines and several...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2009-02-04)
More Articles from Vaccine Weekly
- Clostridium
Research on clostridium published by Y.Z. Yu et al - Cytokines
Research data from Kuwait University, Medical Department update understanding of cytokines - Dental Caries
New data from M. Dinis et al illuminate research in dental caries - Diphtheria
Reports outline diphtheria study results from K.R. Mott et al - Enzyme Research
Data on enzyme research published by researchers at University of Milan - Falciparum Malaria
Research findings from University of California update understanding of falciparum malaria - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
